 |
Texas Administrative Code (Last Updated: March 27,2024) |
 |
TITLE 22. EXAMINING BOARDS |
|
|
PART 9. TEXAS MEDICAL BOARD |
|
|
CHAPTER 198. STANDARDS FOR USE OF INVESTIGATIONAL AGENTS |
| SUBCHAPTER A. STANDARDS FOR USE OF INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, OR DEVICES |
| § 198.1. Purpose |
| § 198.2. Definitions |
| § 198.3. Practice Guidelines for the Use of Investigational Agents |
| § 198.4. Use of Investigational Drugs, Biological Products, or Devices for Patients with Terminal Illnesses |
| SUBCHAPTER B. INVESTIGATIONAL STEM CELL TREATMENTS FOR PATIENTS WITH CERTAIN SEVERE CHRONIC DISEASES OR TERMINAL ILLNESSES |
| § 198.5. Use of Investigational Stem Cell Treatments for Patients with Certain Severe Chronic Diseases or Terminal Illnesses |
| § 198.6. Process and Procedures for IRBs Engaged in the Use of Investigational Stem Cell Treatments for Patients with Certain Severe Chronic Diseases or Terminal Illnesses |